Moderna (MRNA) Acquisitions (2023)

Moderna (MRNA) posted quarterly Acquisitions of $85.0 million for Q1 2023.

Moderna (MRNA) Acquisitions (2023) Analysis & Trends

Moderna has reported Acquisitions for 1 years, with the latest figure at $85.0 million in Q1 2023.

  • Acquisitions for Q1 2023 came in at $85.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $85.0 million (changed N/A YoY), and the FY2023 annual result was $85.0 million, changed N/A from the prior year.
  • Acquisitions steadied at $85.0 million in Q1 2023.
  • Over five years, Acquisitions peaked at $85.0 million in Q1 2023 and troughed at $85.0 million in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Moderna 25.26 Bn 20.13 Bn 52.00 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 85.00 Mn